TESOFENSINE AND METOPROLOL COMBINATION FORMULATION

The present invention relates to a controlled release formulation comprising the active compounds tesofensine and a beta blocker, such as metoprolol or carvedilol, or a pharmaceutically acceptable salt thereof. The invention further relates to use of the controlled release formulation in a method of...

Full description

Saved in:
Bibliographic Details
Main Authors NIELSEN, Peter G, THOMSEN, Mikael S, HØJGAARD, Bent
Format Patent
LanguageEnglish
Lithuanian
Published 10.09.2021
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention relates to a controlled release formulation comprising the active compounds tesofensine and a beta blocker, such as metoprolol or carvedilol, or a pharmaceutically acceptable salt thereof. The invention further relates to use of the controlled release formulation in a method of treatment of diabetes, obesity, or an obesity associated disorder.
Bibliography:Application Number: LT16711521T